| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Retension Pharmaceuticals, Inc.
13G
RTSN · 76135H100
|
8.3% |
10/16/2026
Event 10/9/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.